BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Acatalasia

Below is an extended Acatalasia research listing. Click here to return to the Acatalasia main in depth entry.

Recent Publications on Acatalasia:

Increased susceptibility to oxidant-mediated tissue injury and peritoneal fibrosis in acatalasemic mice.
BACKGROUND: Peritoneal fibrosis is a major complication leading to the...
Direct Link
29th July, 2008
Department of Medicine and Clinical Science, Okayama University Graduate
Drug delivery to peroxisomes: employing unique trafficking mechanisms to target protein therapeutics.
Peroxisomes are multifunctional organelles of all human cells, responsible...
Direct Link
21st December, 2007
Department of Pharmacology, Wayne State University School of Medicine, 540
Catalase deficiency may complicate urate oxidase (rasburicase) therapy.
Patients with low (inherited and acquired) catalase activities who are...
Direct Link
6th December, 2007
Department of Clinical Biochemistry, Molecular Pathology and Clinical
Peroxisomes and aging.
Peroxisomes are indispensable for proper functioning of human cells. They...
Direct Link
24th March, 2007
Department of Pharmacology, Wayne State University School of Medicine, 540
Mammalian catalase: a venerable enzyme with new mysteries.
Mammalian catalase has been the subject of many classic biochemical...
Direct Link
17th March, 2007
Department of Pediatrics, Division of Genetics and Metabolism, University
Effects of post low-dose X-ray irradiation on carbon tetrachloride-induced acatalasemic mice liver damage. 2nd November, 2006
Okayama University Medical School, Japan.
Characterization of acatalasemic erythrocytes treated with low and high dose hydrogen peroxide. Hemolysis and aggregation.
The effects of hydrogen peroxide on normal and acatalasemic erythrocytes...
Direct Link
17th October, 2006
Department of Life Science, Okayama University of Science, 700-0005,
Simple PCR heteroduplex, SSCP mutation screening methods for the detection of novel catalase mutations in Hungarian patients with type 2 diabetes mellitus.
BACKGROUND: The enzyme catalase is the main regulator of hydrogen peroxide...
Direct Link
10th March, 2006
DRC Ltd, Balatonfured, Hungary.
Telmisartan inhibits both oxidative stress and renal fibrosis after unilateral ureteral obstruction in acatalasemic mice.
BACKGROUND: Reactive oxygen species are involved in many of the...
Direct Link
16th February, 2006
Department of Medicine and Clinical Science, Okayama University Graduate
Detection of a novel familial catalase mutation (Hungarian type D) and the possible risk of inherited catalase deficiency for diabetes mellitus.
The enzyme catalase is the main regulator of hydrogen peroxide metabolism....
Direct Link
17th August, 2005
Department of Clinical Biochemistry, Molecular Pathology, and Clinical
Catalase enzyme mutations and their association with diseases. 26th July, 2005
Department of Clinical Analytical Chemistry, Medical and Health Science
Inhibitory effects of prior low-dose X-ray irradiation on carbon tetrachloride-induced hepatopathy in acatalasemic mice. 11th August, 2004
Chair of Medical Radioscience, Okayama University Medical School, Japan.
Methemoglobinemia from hydrogen peroxide in a patient with acatalasemia. 30th July, 2004
Department of Anesthesiology, Tokyo Medical University, Tokyo, Japan.
Acatalasemia sensitizes renal tubular epithelial cells to apoptosis and exacerbates renal fibrosis after unilateral ureteral obstruction.
Tissue homeostasis is determined by the balance between oxidants and...
Direct Link
21st June, 2004
Okayama Univ. Graduate School of Medicine and Dentistry, 2-5-1
The effects of hydrogen peroxide promoted by homocysteine and inherited catalase deficiency on human hypocatalasemic patients. 21st May, 2004
Departments of Clinical Biochemistry and Molecular Pathology and Clinical
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional